Related Experiment Videos
Long-term continuous ambulatory peritoneal dialysis in diabetics
E V Balaskas1, Z Y Yuan, A Gupta
1Division of Nephrology, Toronto Hospital, Ontario, Canada.
Clinical Nephrology
|July 1, 1994
Summary
Diabetic patients with end-stage renal disease can achieve long-term survival on continuous ambulatory peritoneal dialysis (CAPD). This study shows CAPD is a viable option for managing complex diabetic kidney disease patients.
Area of Science:
- Nephrology
- Diabetology
- Geriatrics
Background:
- Diabetic end-stage renal disease (ESRD) presents significant management challenges.
- Long-term outcomes for diabetic ESRD patients on peritoneal dialysis are not well-established.
Purpose of the Study:
- To evaluate the long-term outcomes of diabetic ESRD patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
Main Methods:
- Retrospective analysis of 7 diabetic patients on CAPD for over 5 years.
- Assessment of comorbid conditions, dialysis-related complications, and clinical parameters.
Main Results:
- Patients experienced manageable peritonitis and exit-site infection rates.
- Blood glucose control improved with intraperitoneal insulin, but residual renal function declined.
- Malnutrition was observed in the later stages of the study.
Conclusions:
- Continuous ambulatory peritoneal dialysis (CAPD) is a feasible long-term treatment option for diabetic ESRD patients, including the elderly and those with comorbidities.
- Careful monitoring for malnutrition and declining renal function is essential.